Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Arcadia Biosciences, Inc. (RKDA : NSDQ)

• Company Description    Arcadia Biosciences Inc. is a producer and marketer of plant-based health and wellness products. Arcadia Biosciences Inc. is based in DALLAS. Number of Employees: 8

• Price / Volume Information    Yesterday's Closing Price: $0.92 Daily Weekly Monthly 20 Day Moving Average: 3,076,397 shares Shares Outstanding: 2.06 (millions) Market Capitalization: $1.89 (millions) Beta: 0.52 52 Week High: $5.72 52 Week Low: $0.80 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.26% -17.50% 12 Week -53.33% -56.86% Year To Date -53.57% -57.94%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5956 Sherry Lane Suite 2000 - Dallas,TX 75225 USA ph: 214-974-8921 fax: 530-756-7027 ir@arcadiabio.com http://www.arcadiabio.com

• General Corporate Information    Officers Thomas J. Schaefer - President; Chief Executive Officer Kevin Comcowich - Director Lilian Shackelford Murray - Director Gregory D. Waller - Director Amy Yoder - Director Peer Information Arcadia Biosciences, Inc. (CORR.) Arcadia Biosciences, Inc. (RSPI) Arcadia Biosciences, Inc. (CGXP) Arcadia Biosciences, Inc. (BGEN) Arcadia Biosciences, Inc. (GTBP) Arcadia Biosciences, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 039014303 SIC: 1311 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 2.06 Most Recent Split Date: 3.00 (0.03:1) Beta: 0.52 Market Capitalization: $1.89 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.66 Price/Cash Flow: 0.71 Price / Sales: 0.40 EPS Growth vs. Year Ago Period: -211.05% vs. Previous Quarter: -115.31% Sales Growth vs. Year Ago Period: -8.33% vs. Previous Quarter: 22.09% ROE 03/31/26 - -113.73 12/31/25 - 37.36 09/30/25 - -8.80 ROA 03/31/26 - -68.47 12/31/25 - 23.95 09/30/25 - -5.15 Current Ratio 03/31/26 - 3.79 12/31/25 - 3.09 09/30/25 - 3.67 Quick Ratio 03/31/26 - 3.17 12/31/25 - 2.50 09/30/25 - 3.03 Operating Margin 03/31/26 - -101.60 12/31/25 - 44.26 09/30/25 - -10.67 Net Margin 03/31/26 - -195.94 12/31/25 - -48.15 09/30/25 - -97.97 Pre-Tax Margin 03/31/26 - -195.78 12/31/25 - -47.98 09/30/25 - -97.31 Book Value 03/31/26 - 1.40 12/31/25 - 2.39 09/30/25 - 3.98 Inventory Turnover 03/31/26 - 2.49 12/31/25 - 2.28 09/30/25 - 2.51 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©